Founded by exited entrepreneurs, Science Creates is a Deep Tech ecosystem that enables scientists and engineers to turn their groundbreaking discoveries into disruptive businesses that can revolutionise the health of people and the planet.
By backing founders, we're building capability in the critical technologies — from engineering biology to quantum — that drive economic growth and create the high-skilled jobs of the next decade.
We support our startup community with specialised lab space, expert training and mentoring, a network of partner organisations, and access to investment opportunities. Through our independent charity and public events, we inspire the next generation of scientists and entrepreneurs.




.webp)

Our ethos
We believe the next big breakthroughs will emerge at the intersection of fields like quantum, AI, and biotechnology — and that spinouts are the most powerful way to turn those innovations into global impact.
The first step is empowering those at the forefront of knowledge with the right infrastructure, training, resources and investment.
Science Creates is laying the foundations for bold ideas and innovation to thrive and scale, nationwide.
Designed for flexibility, OMX, our new 30,000 sq ft of lab, office, and meeting space for startups and scaleups is now ready to take new tenants.
Whatever you're working on, there's a desk for you at Science Creates. Join one of the most exciting entrepreneurial communities in Bristol.
We invest in Deep Tech at the pre-seed and seed stages — and our endgame is global impact.



Our focus
Deep Tech refers to innovations based on major breakthroughs in science and engineering, often built on years of research and proprietary technology to solve global challenges. Unlike regular tech, it focuses on transformative, long-term solutions in fields like AI, quantum, engineering biology and advanced materials — the UK government's designated frontier industries.
Deep Tech can revolutionise entire industries, create high-skilled jobs and unlock new economic growth while improving lives.
We specialise in Deep Tech because the social, environmental and economic returns are proportional to the ambition. It demands patient capital and deep technical understanding, and that's exactly what we're built to provide.

Glaia is developing innovative solutions to optimise agricultural plant performance to help food security and fight climate change. Using disruptive technology, its sustainable agrochemicals unlock the potential of the photosynthetic process, enabling plant cells to more efficiently convert energy to biomass to increase crop yields without increasing inputs. This results in greater profits for growers and reduced greenhouse emissions, delivering more sustainable global food production.

Mechanome Bio is transforming drug discovery by fusing mechanomics with multimodal omics to develop novel therapies, decoding the physical forces that drive disease. Through this process that moves beyond the traditional focus on the genome and biochemistry, it uncovers novel biomarkers and targets that reprogram cellular mechano-associated pathways to accelerate safer, more effective precision therapies for complex, hard-to-treat diseases.

PentaBind is designing high performance, programmable aptamers as therapeutic delivery vehicles and active ingredients. It uses generative AI models, supported by wet-laboratory data generation processes, to help produce aptamer drugs that are easy to design, highly selective and ‘invisible’ to the immune system. Its platform enables applications across advanced therapeutics, biomanufacturing and continuous monitoring (for wearables and women's health).



Our versatile spaces can welcome a variety of events, from small meetings to 60-person seminars including catering and a fully licensed bar.
